Patient Assistance Program
Careers
Contact

Pipeline
Leadership
- Management Team
- Board of Directors
Medical Affairs
News & Investors
Careers
Contact

Pipeline
Leadership
Medical Affairs
News & Investors
Careers
Contact

Management Team
Board of Directors

MEDINFO
Adverse Event
Product Quality Complaint
Research Focus
Clinical Trials
CME Grant
Investigator Initiated Study
Medical Writing Grants
Find your field medical director

Atopic Dermatitis
Psoriasis

June 2021

June 2021

June 7, 2021

Dermavant Announces $200 Million of Financing ...

Read More

June 3, 2021

Dermavant Submits New Drug Application (NDA) to FD ...

Read More

For Healthcare Professionals With Medical Questions

Find Your Field Medical Director

Recent Posts

Dermavant Announces Positive Results from Phase 4 Open-Label Trial of VTAMA^® (tapinarof) Cream, 1% for the Treatment of Plaque Psoriasis in the Head and Neck Region in Adults
Dermavant Presents Positive Results from Phase 4 Open-Label Trial of VTAMA^® (tapinarof) Cream, 1% for the Treatment of Intertriginous Plaque Psoriasis in Adults at 43rd Annual Fall Clinical Dermatology Conference
Dermavant to Present New Positive Data from Phase 4, Open Label Trial of VTAMA^® (tapinarof) Cream, 1% for Intertriginous Plaque Psoriasis in Adults and Multiple Clinical Trials of VTAMA cream at the 2023 Fall Clinical Dermatology Conference
Dermavant Champions a Culture that Earns Three Best Workplace Rankings in 2023 by Fortune and Great Place to Work^®
Dermavant Announces New Positive Pruritus Data for VTAMA^®(tapinarof) Cream, 1% in Adults and Children as Young as Two Years Old with Atopic Dermatitis at the EADV Congress 2023

Archives

Categories

Dermavant Sciences
News
RVT-201
RVT-501
RVT-502
RVT-504
Tapinarof

Find Us

Dermavant Sciences, Inc.
3780 Kilroy Airport Way
Suite 250
Long Beach, CA 90806
United States

Company
Medical Information
Compliance Program

Leadership
Careers
Contact
News & Investors

Pipeline
MEDINFO
Clinical Trials
Research Focus
CME Grant

Management Team
Board of Directors

Atopic Dermatitis
Psoriasis

Company
- Leadership
  - Management Team
  - Board of Directors
- Careers
- Contact
- News & Investors
Medical Information
- Pipeline
- MEDINFO
- Clinical Trials
- Research Focus
  - Atopic Dermatitis
  - Psoriasis
- CME Grant
Compliance Program

Copyright © 2023 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of Dermavant Sciences, GmbH.
Privacy Policy | Terms of Use | Terms of Sale – Independent Pharmacies | Terms of Sale – Wholesalers | US Wholesalers